Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment
- PMID: 33459347
- DOI: 10.1002/eji.202048756
Generation of HBsAg-reactive T- and B-cells following HBV vaccination in serological non-responders under hemodialysis treatment
Abstract
HBV vaccination is recommend for hemodialysis patients, but only 50-60% of the patients show seroconversion. HBV vaccine-induced generation of HBV reactive T and B cells could be detected regardless of their capacity to mount a serological response, indicating that patients without seroconversion are potentially protected by their HBV-reactive T cell pool.
Keywords: T cells; anti-HBsAg titer; antigen-specific B cells; hepatitis B virus; renal diseases.
© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.
References
-
- Blaine Hollinger, F., Am. J. Med. 1989. 87: S36-S40.
-
- Olsen, S. K. and Brown, R. S., Kidney Int. 2006. 70: 1897-1904.
-
- Fried, A. J. and Bonilla, F. A., Clin. Microbiol. Rev. 2009. 22: 396-414.
-
- Ritchie, R. F. et al., J. Clin. Lab. Anal. 1998. 12: 363-370.
-
- Cossarizza, A. et al., Eur. J. Immunol. 2019. 49: 1457--1973.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
